| Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond New Edition |
|
Authors: Dennis A. Tosh, Esq
Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond gives you in-depth analysis of the major legal, regulatory, enforcement and litigation events through early 2008 affecting the drug and medical device industries. This book will help attorneys and the industry: - Plan legal strategy in 2008 and beyond,
- Avoid lawsuits,
- Save money, and
- Prevent costly mistakes
The book includes insights from leading attorneys; essential summaries of major cases and court decisions; practice tools; and a case index of nearly 275 cases. The chapters are divided into six broad areas for easy reference – Product Liability; Enforcement and Compliance; Sales & Promotion Compliance; Medical Device Compliance; Food and Drug Administration Amendments Act of 2007; and Clinical Trials.
|
|
About This Publication
This resource provides: - thorough reporting of important developments
- commentary and analysis from prominent attorneys who offer valuable expertise and insight
- practical tips that can give you a heads-up on likely future developments – as well as guidance on best practices that can help you face the challenges confronting FDA-regulated companies and their counsel
- table of cases with nearly 275 case references and a table of practice tools
New for the 2008 Edition: - The $4.85 billion Vioxx settlement, and what it means for product manufacturers, consumers, and mass product liability settlements.
- Important decisions from the U.S. Supreme Court and other federal and state courts on the federal preemption of state law liability claims brought against drug and device manufacturers.
- Sweeping new legislation boosting the FDA’s enforcement powers and new requirements for drug manufacturing, clinical trials and device regulation.
- The latest developments involving the regulation of direct-to-consumer advertising.
- Expanded use of the federal False Claims Act and the growing role of state false claims acts in the face of alleged fraud and abuse involving FDA-regulated products.
Nothing can help drug and device company officials and their counsel deal with these challenging times more than a clear understanding of the latest legal and regulatory developments and their likely effect during the years to come. Thompson’s Drug & Device Enforcement & Litigation: Impact on 2008 and Beyond will help you gain that understanding and prepare you for future events that will profoundly affect the drug and medical device industries. |
|
 |
About Your Order
You can review this product for 30 days. If you cancel within 30 days of receipt, you will receive a full credit upon return of the product together with a request for cancellation.
|
 |
|